A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce
oleh: Nikki Carter, Maryam Clausen, Rebecca A. Halpin, Colin Blackmore, Kang Cai, Oona Delpuech, Alexander Kohlmann, Otto Magnusson, Ruth March, Daniel O’Neill, Kasthuri Prakash, James Sherwood, Tabetha Sundin, Jason Swift, Azar Tarakameh, Marilou Wijdicks, Daniel Wise, Mark Fidock
| Format: | Article |
|---|---|
| Diterbitkan: | Nature Portfolio 2021-06-01 |
Deskripsi
Abstract Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and maintain supply of essential medicines to patients. We describe the development of an internal automated SARS-CoV-2 testing programme including the transformative introduction of saliva as an alternative sample type.